Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer

Stereotactic ablative radiotherapy (SABR) is the main treatment for inoperable early-stage non-small cell lung cancer (NSCLC). Despite the widespread use of SABR, the biological determinants of response to SABR remain poorly investigated. We developed an orthotopic NSCLC animal model to study the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Oweida, Ayman, Sabri, Siham, Al-Rabea, Areej, Ebrahimi, Mojgan, Ruo, Russel, Fraser, Richard, Seuntjens, Jan, Abdulkarim, Bassam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788587/
https://www.ncbi.nlm.nih.gov/pubmed/29416719
http://dx.doi.org/10.18632/oncotarget.22727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788587/
https://www.ncbi.nlm.nih.gov/pubmed/29416719
http://dx.doi.org/10.18632/oncotarget.22727

Ejemplares similares